Cutaneous Adverse Events as a Predictor of Tumor Response Under Anti-PD-1 Therapy for Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cutaneous Adverse Events: A Predictor of Tumour Response Under Anti-PD-1 Therapy for Metastatic Melanoma, A Cohort Analysis of 189 Patients
J Eur Acad Dermatol Venereol 2020 Feb 20;[EPub Ahead of Print], L Bottlaender, M Amini-Adle, D Maucort-Boulch, P Robinson, L Thomas, S DalleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.